Gilead remdesivir study finds only marginal benefit for moderate COVID-19 patients (Reuters) – Moderately ill COVID-19 patients saw their condition improve after a 5-day course of Gilead Sciences Inc’s (GILD.O) […]
The U.S. Food and Drug Administration will review GlaxoSmithKline’s experimental treatment for multiple myeloma, a common form of blood cancer, for a reported side effect which affects the eyes of patients.
Dr. Reddy’s Laboratories’ Foram Vaishnav discusses the role and impact of pharmacovigilance in the pharmaceutical industry.
Johnson & Johnson wins U.S. FDA approval for bladder cancer drugAdvanced bladder cancer, Approvals, Biomarkers, Breakthrough Therapy Designation, FDA, FDA/Regulatory, Fibroblast Growth Factor Receptor (FGFR) Inhibitors, Genetic Mutations, New Drug Application (NDA), Pricing, Priority Review, Shares, Side Effects
Johnson & Johnson’s drug Balversa won U.S. approval as the first targeted therapy for advanced bladder cancer, the Food and Drug Administration announced.
Roche’s seven-year-old rheumatoid arthritis drug Actemra is being linked to hundreds of deaths due to undisclosed side effects.
(Reuters Health) – According to a reanalysis of the original data from a 2001 study of paroxetine (Paxil) for teens with major depression, the drug was not effective and led […]
A medical journal criticized British drugmaker GlaxoSmithKline on Thursday for delaying access to key data from a trial of its antidepressant Seroxat that would have shown earlier that it is […]
Still no Rx for patient adherence Pharma limited in what it can do, but can still have a positive impact Patient adherence remains a complex puzzle with no simple […]
SEATTLE, Aug. 4, 2015 /PRNewswire/ — Dr. Keesha Ewers of The Functional Sexology Institute states the potential FDA approval of flibanserin, or what is being touted as “pink Viagra,” sets women […]
Companies fail to report roughly one in 10 serious and unexpected medication side effects to the U.S. Food and Drug Administration (FDA) within a 15-day window specified by federal regulations […]